Key factors determining the development of SARS-CoV-2 testing strategies in EU countries: a mixed-methods study
In general, the scope of the testing strategy in European countries included in this study expanded as the pandemic progressed. This study identified key factors discussed by European experts interviewed that contributed to the development of SARS-CoV-2 testing strategies across European countries.
Authors
- Marion Koopmans (ORCID: https://orcid.org/0000-0002-5204-2312)
- L S Kengne Kamga (ORCID: https://orcid.org/0000-0003-4615-4606)
- Martine C. de Vries (ORCID: https://orcid.org/0000-0002-3178-7470)
- A C G Voordouw
- Aura Timen (ORCID: https://orcid.org/0000-0002-5793-5443)
Institutions
- Radboud University Nijmegen (NL)
- Radboud University Medical Center (NL)
- National Institute for Public Health and the Environment (NL)
- Vrije Universiteit Amsterdam (NL)
- Amsterdam UMC Location Vrije Universiteit Amsterdam (NL)
Publication Details
- Journal
- BMJ Public Health
- Published
- 2025-03-01
- DOI
- https://doi.org/10.1136/bmjph-2024-001269
- Primary Topic
- SARS-CoV-2 detection and testing
- Type
- article
- Field-Weighted Citation Impact
- 0.00
Funders
- European Commission